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Abstract 
We have synthesized calcium phosphate cements doped with different amounts of 
magnesium (Mg-CPC) with a twofold purpose: i)  to evaluate in vitro the osteoblast cell 
response to this material, and ii) to compare the bone regeneration capacity of the doped 
material with a calcium cement prepared without magnesium (CPC). Cell proliferation 
and in vivo response increased in the Mg-CPCs in comparison with CPC. The Mg-CPCs 
have promoted higher new bone formation than the CPC (p < 0.05). The 
cytocompatibility and histomorfometric analysis performed in the rabbit calvaria 
showed that the incorporation of magnesium ions in CPC improves osteoblasts 
proliferation and provides higher new bone formation. The development of a bone 
substitute with controllable biodegradable properties and improved bone regeneration 
can be considered a step towards personalized therapy that can adapt to patient needs 
and clinical situations. 
 
Keywords: calcium phosphate cement; brushite; magnesium; osteoblast; bone 
regeneration. 
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1. Introduction 
Nowadays there is a high clinical demand for synthetic bone materials due to 
drawbacks associated with biological bone grafts [1]. Although autogenous bone is still 
considered to be the gold standard in bone regeneration, the harvesting of autogenous 
bone has disadvantages such as donor site surgery, extended surgery time with the 
consequent risk of complications, and limited amount of graft material. For these 
reasons, there has been an increased research in bone replacement biomaterials in the 
last decades. The calcium phosphate cement (CPC) has gained clinical acceptance for 
bone substitution and bone augmentation due to their similarities with the mineral bone 
composition [2,3], and to their biocompatibility, bioactivity and osteoconductivity [4]. 
Many efforts have been expended to develop CPC that mimic the bone tissue [5] and 
different strategies were proposed to reach that goal. Namely: development of porous 
cements to enhance material resorption, tissue colonization and angiogenesis [6], 
incorporation of some specific ions which play relevant roles in bone metabolism [7,8], 
and finally the addition of drugs and growth factors to the CPC matrix [9,10,11].  
The incorporation of ions into calcium phosphate cements is of great importance 
because many biological tissues, such as bone or teeth are composed of an apatitic 
mineral phase containing tiny amounts of other elements [12] such as magnesium, 
strontium and silica. Magnesium (Mg) is the fourth highest abundant cation in the 
human body after Ca, K, and Na, and the 50 % of the total Mg is found in bone tissue 
whereas only 1.0 % is found in extracellular fluid. Mg ions are involved in various 
biological processes such as cellular processes of proliferation and differentiation, the 
cell-matrix interaction, and the normal function of parathyroid glands and metabolism 
of vitamin D. Furthermore, the deficiency of Mg in bone seems to be a risk factor for 
osteoporosis in humans [13]. The addition of Mg within CPC has attracted attention 
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because of the potential beneficial effects of Mg on the physicochemical properties of 
the minerals [14,15] and also because the improvement of the bone metabolism [16]. 
Mg2+ is considered the most important ion used in calcium substitution, since its 
incorporation into materials leads to a change in their biological and chemical 
performance [17]. Recently, it was reported that the amount of Mg2+ into calcified 
tissues is associated with the apatitic phase decrease, and that strong calcification leads 
to changes of the bone matrix that determines the bone fragility [18]. Currently, the 
incorporation of Mg2+ is considered a promising route for increasing the bioactivity of 
bone-engineering scaffolds [19,20]. For the above reasons, we consider that the 
incorporation of Mg2+ ions within brushite cement presents a biological approach 
towards increasing the bioactivity of the brushite scaffolds.  
  
2.        Material and Methods 
2.1 Cement formulations 
The preparation of the new biomaterial is explained elsewhere [21] but herein a 
brief description of the synthesis is given. β-tricalcium phosphate (β-TCP) was prepared 
by sintering calcium phosphate dihydrate (CaHPO4.2H2O) (Sigma-Aldrich, Spain) and 
calcium carbonate (CaCO3) (Sigma-Aldrich, Spain) in a molar ratio of 2:1 at 1000 ºC 
for 12 h [Eq. (1)]. Mg-substituted β-TCP (Mg-TCP) was produced by replacing calcium 
phosphate dihydrate with magnesium phosphate 3-hydrate (MgHPO4.3H2O) (Sigma-
Aldrich, Spain) in the synthesis reaction of β-TCP,  
CaCO3 + 2(CaHPO4.2H2O) →  E-Ca3(PO4)2 + 5H2O + CO2     (1) 
resulting in a molar Mg/(Mg+Ca) ratio of the reactants between 0 and 40 % (Table 1). 
The (Mg+Ca)/P ratio was maintained constant at 1.5. Thereafter, the sintered ceramics 
were crushed and sieved with 200 μm pore size-mesh.  
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The as prepared powder was mixed with monocalcium phosphate monohydrate 
(Sigma-Aldrich, Spain), at equimolar ratio, using a mortar with pestle and subsequently 
it was reacted with water at a powder to liquid ratio (P/L) of 3.0 g.ml-1, to obtain the 
cements. For the in vitro study, the sample dimensions were 15 mm diameter and 2 mm 
thick, whereas for the in vivo study, the cements were crushed and sieved to grain size 
between 0.5 and 0.8 mm. Finally, the samples were disinfected with ethanol 70 % for 1 
hour.  
 
2.2  Cell studies 
2.2.1. Cell proliferation 
The evaluation of the cell response to the cements was performed using the 
osteoblast cell line MG-63. The cells were maintained in cell culture flasks in an 
incubator with 5 % CO2 and 95 % air atmosphere at 37 ºC. The cell culture medium 
consists  of  Dulbecco’s  modified  with Eagle (Sigma-Aldrich, UK) supplemented with 5 
ml/L L-glutamine (Sigma-Aldrich, UK), 100 IU/ml penicillin, 100 µg/ml streptomycin 
(Sigma-Aldrich, UK), and 100 ml/L fetal bovine serum that was changed every 2 days. 
The confluent cells were dissociated with trypsin (Sigma-Aldrich, UK) and subcultured 
to three passages which were used for tests. 
Four disk-shaped samples, for each of the cements, were prepared in silicon 
molds of 14 mm diameter and 2-3 mm thickness and then disinfected using 70 % 
ethanol. Sterile samples were placed in quadruplicate into 24-well plate for 3, 5, 7 and 
10 days. Samples were preconditioned for 24 h by introducing 2 ml of medium per well. 
After preconditioning the medium was removed and osteoblasts were seeded on top of 
the cements discs at an initial density of 25000 cells/ml/discs and maintained in an 
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incubator with a humidified atmosphere of 5 % CO2 in air at 37 ºC. The culture medium 
was exchanged every second day. 
The cell proliferation was evaluated at 3, 5, 7 and 10 days. At each time point 
the samples were rinsed twice with PBS to remove the non-attached cells. The attached 
cells were dissociated with 1 ml of trypsin per well in incubator with 5 % CO2 at 37 °C 
for 7 minutes. Then, the enzymatic activity was neutralized with 1 ml of the medium. 
Cell quantification was performed with a hemocytometer (Neubauer chamber) by 
capillarity, and subsequently the cells were observed with an optical microscopy. 
 
2.2.2. Cell morphology 
Morphological evaluation of the cells on the surfaces of the cement specimens 
was carried out as follows: the cells were cultured onto the discs as mentioned above, 
after of each study time (3, 5, 7 and 10 days) the medium was removed from each well 
containing the sample and the cell-cultured specimens were rinsed with phosphate 
buffered saline (PBS) twice, and then, the cells were fixed with 2 ml/well of 6.25% 
glutaraldehyde (Sigma-Aldrich, Spain). After 30 min, they were rinsed again and kept 
in PBS at 4 ºC. After cell fixation, the specimens were dehydrated in ethanol solutions 
of varying concentration (15, 30, 50, 70, 90, and 100 %) for about 30 min at each 
concentration. The specimens were then dried, using the critical-point dry technique, 
and subsequently they were coated with carbon using the evaporator Balzers MED-010 
(Balzers Union, Liechtenstein), and then coated with gold using metallization K550X 
(Emitech, Taiwan). The surface images were recorded using scanning electron 
microscopy JSM-6400. 
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2.3 Experimental animal model 
In vivo experiments were conducted in accordance with the guidelines laid down 
by the European Communities, Council Directive of 24 November 1986 (86/609/EEC). 
Before starting the in vivo animal study, the protocol was approved by the Ethics 
Committee for Animal Experimentation at the Universidad Rey Juan Carlos (Madrid), 
and adequate measurements were taken to minimize pain and discomfort in the animals. 
Seven New Zealand rabbits, six-month-old, and weighing between 2.4 and 3.1 
kg were used. The animals were accommodated in the official stable for animal assays 
of the Universidad Rey Juan Carlos, at 22–24 ºC with 55–70 % humidity, light cycles of 
12 h, and air renewal 15 times/h. Before surgery, they underwent a head haircut, then 
they were weighed and with this datum it was calculated the volume of anesthetic for 
each animal. 
 
2.3.1. Operative procedure 
The rabbits were anesthetized by intramuscular injection of Buprenorfina 
(Schering plough, Spain) 0.3 ml, Ketamina (Merial, Spain) 0.4 ml/kg and Xilacina 
(Bayer, Germany) 0.25 ml/kg. The animals were placed prone on the operating table 
and then an antiseptic solution (Iodopovidone) was applied over the surgical field. The 
surgery begins by making an incision in the midline of the head,  with a No. 15 scalpel, 
and then the skin and periosteum was lifted and moved laterally using a periosteal 
elevator to leave the calvarial bone exposed (Figure 1A). Bone defects were produced in 
the calvarial bone plate using a trephine of 10 mm in diameter and afterwards the bone 
block was removed with a curette (Figure 1B). During bone drilling, the surgical field 
was continuously irrigated with sterile saline solution to reduce thermal damage. Once 
the 2 bone defects were achieved (Figure 1C) we proceed to fill the defects with cement 
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granules (Figure 1D). After this, the periosteum was repositioned in its place and 
sutured by simple points with resorbable sutures (3/0) and skin with was sutured with 
silk (3/0). Once the surgery was complete, we applied an antiseptic solution 
(Iodopovidone) to each animal and all of them received antibiotics (Terramycin) and 
Buprenorphine in the drinking water (2 doses of 3 ml per day for 2 days). 
Eight weeks after surgery, the rabbits were euthanized by means of a lethal 
intravenous injection (30 mg/kg) of pentobarbitone sodium (Vétoquinol, France). The 
bone blocks containing the defects filled with cements were removed with a safety 
margin of 1 cm around the defect using a high-speed cutting disk under continuous 
saline irrigation. Finally, the bone samples were fixed in 10 % buffered formalin for 5 
days to be processed for histological and histomorphometric analysis. 
 
2.3.2. Histology 
The bone tissue blocks were dehydrated in graded ethanol series (70–100 %), 
and then embedded into resin methylmethacrylate (Kulzer, Germany) and polymerized. 
Polymerization was carried out for 24 h under low intensity UV light, followed by 1 h 
under high-intensity UV light to assure complete polymerization. 
The samples were cut along the longitudinal axis using a diamond circular 
(Remet, Italy) to obtain thin sections (500 µm) and then were polished (Remet, Italy) 
until a final thickness around 80 µm. The resulting sections were stained using toluidine 
blue (Panreac - Spain). The samples were observed using optical microscopy (Nikon, 
Japan) for the histological evaluation.  
The defects were assessed considering the cement incorporation, the cement 
resorption, and the new bone formation as well as tissue behavior in the regions 
adjacent to the cement. Following light microscopy, the same sections were prepared for 
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backscatter scanning electron microscopy (B-SEM). For this, specimens were glued on 
a copper holder and their surfaces were highly polished with diamond paste. Thereafter, 
the surfaces were sputtered with a carbon layer and examined using a scanning electron 
microscopy with the backscatter detector. 
 
2.3.3. Histomorphometry 
The histomorphometric evaluation was carried out using an optical microscope. 
By means of the digital camera (Nikon, Japan) the images were captured with 2x 
magnification and transferred to the computer. The images were analyzed using image 
analysis software NIS (Nikon, Japan). In each section we measured the total area, the 
new bone area, and the residual cement area. These data permit to calculate the 
following parameters: average bone volume formed (BV) and volume of the remaining 
graft material (RG). 
BV (%)   =  Newly formed bone volume   x 100 
                      Total sample volume   
 
RG (%)   =  Remaining graft volume   x  100 
                     Total sample volume  
 
2.4 Statistical analysis: 
Statistical analysis was evaluated using Origin 8 (OriginLab Corporation, USA). 
The data rows were examined with the Shapiro-Wilk test and it was proved that they are 
normally distributed. The data were analyzed using analysis  of  variance  (ANOVA)  (α  =  
5 %) to test the hypothesis that there were no differences in the parameters for all 
groups. Values of p < 0.05 were considered statistically significant. The post-hoc test, 
according to Tukey, allowed assessment of the significance for intra- and intergroup 
differences. 
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3.       Results 
3.1 In vitro cell study 
 To determine the cytocompatibility of our cements we studied the in vitro 
response of osteoblast cell line MG-63 on the surface of the cements. The Figure 2 
shows the change in numbers of viable cells attached on cements as a function of time. 
After an initial period of attachment to the surface of the cements, the osteoblasts began 
to proliferate showing significant differences in cell numbers after 3, 5, 7 and 10 days (p 
≤   0.0001) Table 2 on all samples. Cell proliferation was affected by the addition of 
magnesium in the CPC and the cell proliferation increases with increasing concentration 
of magnesium. The osteoblasts exhibit better proliferation on all Mg-CPC compared to 
control group of CPC.  
Figure 3 shows the morphology of the osteoblasts cells that appear well attached 
onto the surface of all cements. You can view SEM images of the materials without the 
cells in the previous paper published [21]. The cells cultured on cements without Mg 
substitution (Figures 3A and 3B correspond to control sample) are well adapted to the 
surface of the cement after the third and fifth day of cultivation. The cells grown on 6.67 
% Mg-CPC are shown in figures 3C and 3D. The cells adhered to the surface of the 
cement have a round shape and seem to be in the extension process in which they 
appear flattened, elongated and extended. After five days of culture, the cells proliferate 
and start to penetrate the pores as shown in figures 3F and 3H that correspond to 26.67 
% Mg-CPC and 40 % Mg-CPC respectively. On the seventh day of culture, the cells are 
covering the entire surface. In these figures we observe some broken cells whose 
presence is attributed to the fixing and dehydration processes of the samples that can 
sometimes be very aggressive with the cells. 
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3.3 In vivo study 
Once the in vitro studies have demonstrated the good cytocompatibility of the 
Mg-CPCs, the assay in animal models is the last step in evaluating the biocompatibility 
of such materials. It is worth to say that there were no surgical complications during the 
preparation of bone defects and filling with experimental biomaterials. The seven 
animals recovered well from surgery and no animals were lost during the study. 
 
3.3.1. Clinical observations 
The diet and activity of all rabbits were normal and it was not visually observed 
any sign of inflammatory tissue reactions after operation. The process of healing was 
uneventful in all animals as no complications were observed. At 8 weeks, we observed a 
normal healing of skin in the operated area in all animals. All cements were well 
incorporated   to   the   adjacent   bone   and   they   did   not   elicit   an   obvious   inflammatory  
reaction in the adjacent soft-tissue such as edema, reddening, or hypervascularity. Some 
residual cement granules can be appreciated after 8 weeks of surgery, however there are 
no signs of displacement or migration of the granules. 
 
3.3.2. Histological and B-SEM observations 
The negative control group refers to the empty cavities (without biomaterial) that 
was considered a critical size defect (10 mm) since it can not be filled with new bone 
within the investigated time period (8 weeks), even though a small amount of peripheral 
bone was formed, as illustrated in Figure 4A. 
However, light microscopy and the B-SEM micrographs of the core biopsies of 
the control sample (CPC without Mg) show residual cement granules surrounded by 
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new bone (Figure 4B and 4C), with native bone visible at both ends. The grays levels of 
the B-SEM view indicate different degrees of mineralization.  
On the other hand, in the critical defects that were fully filled with 6.67 % Mg-
CPC, 26.67 % Mg-CPC and 40 % Mg-CPC new bone formation was observed and also 
some residual graft granules (Figures 5). The images obtained with light microscope 
and B-SEM in the cements prepared with magnesium are consistent with those obtained 
with the control cement: residual graft granules surrounded by new bone in the core. 
Moreover, some graft granules shown osteoconduction while others have minimal 
contact with the bone. 
 
      
3.3.3. Histomorphometric results: 
The histomorphometric measurements of all samples were performed on the 
histology sections where the bone was colored blue or violet, and the residual cement 
appears brown or black. The results of the histomorphometric analysis gave the 
percentage of new bone and also the remaining graft for the biomaterials: i) CPC 
(without Mg), NB=11 % ± 2,  RG= 40 % ± 7 ;  ii) 6.67 % Mg-CPC, NB=26 % ± 5, 
RG=27 % ± 3;  iii)  26.67 % Mg-CPC, NB=19 % ± 3, RG=52 % ± 5; and 40 % Mg-
CPC, NB= 32 % ± 5, RG=20 % ± 3. 
Statistical analysis of the sections, using a one way factorial ANOVA design, 
showed significant differences in bone formation, as well as in remaining cement, 
between the various cements with Mg and the control (p < 0.05) (Figure 6 and table 3 
and 4).  
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4.      Discussion 
The rationale to use bone cells to analyze the cellular response of the materials is 
because our work aims to develop new materials with applications in bone repair and 
bone regeneration. We have chosen for these trials the MG-63 cell line, which consists 
of human osteosarcoma cells and osteoblast-like cells which are responsible for bone 
formation. This is a well known cell line that is commonly employed to study the 
interactions of cells with biomaterials [22,23]. 
The cellular response to a biomaterial, such as proliferation and differentiation, 
not only depend on the chemical composition of the material, but also on the 
morphology of its surface [24], which plays a crucial role in determining cell behavior 
and influences the amount of ions released from the biomaterial [25]. The cell 
proliferation studies provide information on the behavior of a material in relation to a 
control, in this case CPC (without Mg), indicating if the new material somehow 
improves or worsens the cell behavior. Our results show an increased cell proliferation 
in the Mg-CPCs in comparison with the control cement. These results could be 
attributed to the role of Mg in the deposition and bone mineralization [26], but there is 
no complete agreement on this point. Thus, some previous studies have demonstrated 
that in addition to Mg some other ions such as Ca and Si can also be released to the 
medium, thus also contributing to the proliferation and differentiation of osteoblasts 
[27,28]. Other authors refer that the release of magnesium ions does not cause local or 
systemic toxicity, and may have beneficial effects on the cellular response in areas 
where they are located [29]. Moreover, the magnesium added to calcium phosphate 
cements improves the adhesion of osteoblasts, it is suggested that the binding of cells to 
biomaterials plays an important role in the rapid restoration of the defective area [30].  
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The morphology of the surface also influences the behavior of the osteoblasts 
cultured on it [31]. The results of SEM (see Figure 3) revealed that the cells are well 
spread and in intimate contact with the surface of the cement during the 10 day test. 
Usually, once the cells have reached confluence, stops proliferating. However, the cell 
line used form multilayers, i.e., after reaching confluence and complete a monolayer, 
the cells continued to grow, forming more than one layer. Due to the growth 
characteristics of osteosarcoma cell lines differs significantly from that of osteoblasts.  
All osteosarcoma cell lines reveal a 2 to 3-fold greater mean doubling-time and a 15 to 
20-fold higher saturation density than osteoblasts [32]. 
For the in vivo study, we selected rabbit as animal model because according to 
Frame [33], in the calvaria of this animal there is an adequate area of cortical and 
spongy bone that permits repairing bone cavities. Furthermore, the calvaria bone of 
rabbit is an excellent region for carrying out bone substitution studies that later can be 
used in the jaws, due to the similarity that exists between this bone and the human jaw. 
From an embrionary point of view they have the same intramembranous origin, 
morphologically they are made up of two cortical bones separated by medullar bone, 
and physiologically they have the same repair pattern. In addition, the rabbit is an 
appropriate model to study the formation and remodeling period of bone (called Sigma) 
since these phenomena are around three times faster in rabbits (6 weeks) than in humans 
(about 6 months). We chose 8 week experiments to ensure good bone neo-formation 
and remodeling, since in 4 weeks only is possible to evaluate the biocompatibility of the 
material, and 12 weeks are not necessary inasmuch as do not provide more information. 
In addition to the above reasons, rabbits are cheap, accessible, easy to handle and 
anesthetize. 
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It has been determined that the bone defect must not be less than the critical size 
defect [34], that in rabbit calvarium is controversial, as some authors consider the size 
of 15 mm [35] whereas for other authors the critical size is around 9 and 10 mm [36]. 
Our results show that after 8 weeks, the spontaneous bone repair was not sufficient to 
promote complete healing in the empty cavities of 10 mm. These results agree with 
various authors that found that in 8 weeks the spontaneous regeneration does not 
provide complete bone repair [37]. So, we can assume that the bone repair found in this 
work is related to the filling of the cavities with the calcium phosphate cements. 
Through histological analysis, we observed that the new materials promote new-
bone formation within the defects, when they were compared with control, being the 
osteoconduction the responsible for the repair in all experimental groups. Moreover, we 
determined the presence of histological continuity between cement and bone tissue 
without fibrous tissue interface. The mechanism of osseointegration of calcium 
phosphate cements is called osteotransduction and is a peculiarity of this group of 
materials. In this case, the implanted material is directly involved in the bone 
replacement, since formation of new bone takes place at the same time the material is 
degraded by osteoclasts [38]. 
Furthermore, together with the new bone formation, we found progressive 
degradation of the granules, so that, after 8 weeks, it is possible to observe rests of 
cement granules surrounded by bone tissue. The remodeling experienced by the newly 
formed bone is correlated with the cycles of resorption and bone apposition that 
characterize normal bone. This implies the existence of a dynamic interface, called 
coalescence, that relates the material implanted with the apatitic crystals deposited in 
the bone matrix [39].   
AC
CE
PT
ED
 M
AN
US
CR
IPT
ACCEPTED MANUSCRIPT
15 
 
The absence of inflammatory manifestations or postoperative infections in any 
rabbit is similar to the results reported by Yu et al [40] who studied a magnesium 
phosphate cement as a biodegradable adhesive cement for fracture healing. Overall, the 
studies suggest that calcium phosphate cements substituted with magnesium are safe, 
and may have application in fractures fixation. 
Histomorphometric measurements quantify the remains of the implanted bone 
cements, and is an indicator of the rate of resorption of biomaterials. We have found an 
increased resorption of the cements with Mg, which seems to indicate  that the addition 
of Mg accelerates the degradation of these materials in agreement with the results 
reported by Zeng et al [41]. Furthermore, the histomorphometric analysis is also able to 
quantify new bone formation. The statistical analysis of histomorphometric 
measurements reveals, through the Tukey test at 5 % probability, a significant 
difference between experimental groups. 
In bone regeneration, the use of osteoconductive substitutes is contraindicated in 
the repair of large defects, because the bone regeneration with this type of material is 
restricted to the periphery of the implant. Therefore, for a complete bone repair it is 
important the combination of a osteoconductive matrix with osteoinductive substances, 
such as growth factors [42]. The clinical application of Mg-CPCs seems possible 
because their versatility to meet specific requirements concerning bone replacement in 
musculoskeletal surgery. 
 
5. Conclusions 
The development of bone substitute with controllable biodegradable properties 
and improved bone regeneration is a step toward personalized therapy that can adapt to 
patient needs and clinical situations. Herein, we suggest that the employment of 
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magnesium ions could improve the clinical efficiency of calcium phosphate cements 
and modify the pace of their biodegradation.   
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Figure 1.  A) Rabbit´s calvaria exposed; B) removal bone block; C) bone defects 
exposed; D) bone defects filled with bone substitute. 
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Figure 2. Cell proliferation after seeding on CPC and Mg-CPCs  
(Error bars represent SD).  
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Figure 3. SEM observations of MG-63 cell morphology on different cements after three 
and five days of culture 
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Figure 4. Bone regeneration within a critical defect without cement (A). . Section of the 
control sample (CPC without Mg). (B) Light microscopy of the bone core, new bone 
(NB) was evident in contact with remaining graft (RG). (C) The findings of light 
microscopy were confirmed using B-SEM (upper panel), the gray levels indicate 
different degrees of mineralization. (2x) 
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Figure 5. Section of critical defects that were fully filled with 6.67% Mg-CPC (A and 
B), 26.67% Mg-CPC (C and D) and 40% Mg-CPC (E and F). (2x) 
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Figura 6. A) Box plot of bone formation of CPC (without Mg), and Mg-CPCs. B) Box 
plot of remaining graft of CPC (without Mg), and Mg-CPCs. The black thick lines 
indicate the median values; ▫ = mean values and the vertical black lines indicate 
whiskers outlier 1.5; * = maximum and minimum values 
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Table 1. Samples containing different amounts of Mg (from 0 
to 40 % of Ca substituted by Mg) 
Samples CaHPO4.2H2O 
[mol] 
MgHPO4.3H2O 
[mol] 
CaCO3 
[mol] 
[Mg(Mg+Ca)] 
(%) 
β-TCP 2 0 1 0 
6.67% Mg-TCP 1.8 0.2 1 6.67 % 
26.67% Mg-TCP 1.2 0.8 1 26.67 % 
40% Mg-TCP 0.8 1.2 1 40 % 
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Table 2. ANOVA (Two-way) statistical analysis of the in vitro study (p < 0.05). 
 
Source Sum of Square gl Mean Square F Value p < 0.05 
Material 18457.38 3 717.18 929.13 < 0.0001 
Time 56819.81 3 3813.70 865.75 < 0.0001 
Material * Time 9693.13 9 162.65 33.38 < 0.0001 
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Table 3. Statistical analysis of the bone formation (p < 0.05). 
 
A. ANOVA (One-way) 
Source Sum of Square gl Mean Square F Value p < 0.05 
Inter-group 1163.72 3 290.93 22.43 < 0.0001 
Intra-gropu 350.17 27 12.97   
Total 1513.89 30    
 
 B. Tukey test  
Groups Mean difference p < 0.05 
CPC - 6.67% Mg-CPC 16.84 < 0.0001 
CPC - 26.67% Mg-CPC 8.57 < 0.0001 
CPC - 40% Mg-CPC 21.47 < 0.0001 
26.67% Mg-CPC - 6.67% Mg-CPC -8.27 < 0.0001 
26.67% Mg-CPC - 40% Mg-CPC 12.90 < 0.0001 
40% Mg-CPC - 6.67% Mg-CPC 4.63 > 0.05 
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Table 4. Statistical analysis of the remaining graft (p < 0.05). 
 
A. ANOVA (One-way) 
Source Sum of Square gl Mean Square F Value p < 0.05 
Inter-group 5392.55 3 1348.14 37.35 < 0.0001 
Intra-gropu 1119.05 27 36.10   
Total 6511.59 30    
 
 B. Tukey test 
Groups Mean difference p < 0.05 
CPC - 6.67% Mg-CPC -14.55 < 0.0001 
CPC - 26.67% Mg-CPC 12.96 < 0.0001 
CPC - 40% Mg-CPC -19.95 < 0.0001 
26.67% Mg-CPC - 6.67% Mg-CPC -27.50 < 0.0001 
26.67% Mg-CPC - 40% Mg-CPC -32.91 < 0.0001 
40% Mg-CPC - 6.67% Mg-CPC -5.40 > 0.05 
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Highlights: 
 
x The Mg-CPCs promote higher new bone formation than the CPC. 
 
x The incorporation of magnesium ions in CPC improves osteoblasts proliferation. 
 
x Mg-CPC is a bone substitute with controllable biodegradable properties. 
 
x We suggest that the use of Mg ions could improve the clinical efficiency of CPCs. 
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